Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Photodynamic Therapy in Unresectable Cholangiocarcinoma
NCT00869635Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Feb 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in cholangiocarcinoma (CCA), sponsored by Asan Medical Center. Started Feb 2009; status: completed.
02
Drugs
tegafur
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT00869635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869635.